61 – 70 of 159
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Smoking and Long-Term Risk of Type 2 Diabetes: The EPIC-InterAct Study in European Populations.
- Contribution to journal › Article
-
Mark
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment.
- Contribution to journal › Article
-
Mark
HARMONY 3: 104-Week Randomized, Double-Blind, Placebo- and Active-Controlled Trial Assessing the Efficacy and Safety of Albiglutide Compared With Placebo, Sitagliptin, and Glimepiride in Patients With Type 2 Diabetes Taking Metformin.
- Contribution to journal › Article
-
Mark
Effects of Weight Loss, Weight Cycling, and Weight Loss Maintenance on Diabetes Incidence and Change in Cardiometabolic Traits in the Diabetes Prevention Program.
- Contribution to journal › Article
-
Mark
Advancing Basal Insulin Replacement in Type 2 Diabetes Inadequately Controlled With Insulin Glargine Plus Oral Agents: A Comparison of Adding Albiglutide, a Weekly GLP-1 Receptor Agonist, Versus Thrice-Daily Prandial Insulin Lispro.
- Contribution to journal › Article
- 2013
-
Mark
Gene-Environment and Gene-Treatment Interactions in Type 2 Diabetes
- Contribution to journal › Scientific review
-
Mark
Ethnic Differences in the Relationship Between Insulin Sensitivity and Insulin Response A systematic review and meta-analysis
- Contribution to journal › Article
-
Mark
Response to Comment on: Saisho et al. beta-Cell Mass and Turnover in Humans: Effects of Obesity and Aging. Diabetes Care 2013;36:111-117
- Contribution to journal › Letter
-
Mark
Age at Menarche and Type 2 Diabetes Risk The EPIC-InterAct study
- Contribution to journal › Article
-
Mark
Age at Menopause, Reproductive Life Span, and Type 2 Diabetes Risk
- Contribution to journal › Article
